What is Prolific Sciences?
Prolific Sciences operates as a high-caliber resource solutions provider, bridging the critical talent gap in the Pharmaceutical, Biotech, and Medical Device industries. By offering specialized consulting in Biostatistics, SAS Programming, and Clinical Data Management, the firm serves as a vital partner for organizations navigating complex regulatory landscapes. Beyond its core life sciences focus, the company maintains a robust portfolio of managed IT services and technical support, providing a diversified revenue stream that stabilizes its market position. This dual-focus approach allows Prolific Sciences to leverage deep domain expertise while maintaining the agility required to support the evolving infrastructure needs of small and medium-sized enterprises.
How much funding has Prolific Sciences raised?
Prolific Sciences has raised a total of $41K across 1 funding round:
Debt
$41K
Debt (2021): $41K with participation from PPP
Key Investors in Prolific Sciences
PPP
Public-Private Partnership
What's next for Prolific Sciences?
With the recent infusion of capital, Prolific Sciences is poised to scale its service delivery capabilities and expand its reach into new geographic markets. The strategic deployment of these funds will likely prioritize the acquisition of top-tier technical talent and the enhancement of its proprietary consulting frameworks. As the demand for clinical data integrity and specialized IT staffing continues to rise, the company is strategically positioned to capture additional market share. Future growth will likely center on deepening client relationships through high-value managed services, ensuring that Prolific Sciences remains a cornerstone provider for firms requiring precision-driven resource solutions in an increasingly data-centric global economy.
See full Prolific Sciences company page
